Melanoma—Part 1: epidemiology, risk factors, and prevention

#### Summary points The incidence of melanoma has risen over the past 30 years in most white populations.1 2 However, in some parts of the world incidence rates are stable or falling. Although large scale primary prevention programmes such as public health education campaigns aimed at reducing exposure to sun may lead to reduced incidence, such programmes have not yet been proved effective. However, melanoma is highly amenable to secondary prevention through early detection. Being able to recognise a melanoma early is an important skill for primary healthcare practitioners. In this first article of a two part series on melanoma, we examine the evidence on the genetic epidemiology of melanoma and outline the complex interactions between incidence, mortality, and survival trends; we also discuss the evidence for prevention. Although melanoma remains a relatively rare tumour, many European countries show an annual increase in incidence above 2%; in some northern European countries, however, no significant increase has been observed.1 Between 1992 and 2005, the annual increase in incidence rates of melanoma in the United States was 2.3% for all races and 2.8% in white populations.3 Queensland in Australia had an increase in incidence of 1.4% for males and 0.7% for females during 1982 to 2001.4 Most recent incidence data show that in some …

[1]  G. Giles,et al.  Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994 , 1996, BMJ.

[2]  P. Autier Cutaneous malignant melanoma: facts about sunbeds and sunscreen , 2005, Expert review of anticancer therapy.

[3]  J. Bulliard,et al.  Comparison of the site distribution of melanoma in New Zealand and Canada , 1997, International journal of cancer.

[4]  E. Holly,et al.  Incidence of cutaneous melanoma among non-Hispanic Whites, Hispanics, Asians, and Blacks: an analysis of California Cancer Registry data, 1988-93 , 1997, Cancer Causes & Control.

[5]  G. Colditz,et al.  Risk Factors for Melanoma by Body Site , 2005, Cancer Epidemiology Biomarkers & Prevention.

[6]  Arjun Chanmugam,et al.  Cutaneous malignant melanoma. , 2006, Mayo Clinic proceedings.

[7]  H. Olsson,et al.  Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. , 1994, American journal of epidemiology.

[8]  J. Coebergh,et al.  A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. , 2005, European journal of cancer.

[9]  C. Berking,et al.  Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma , 2006, Archives of Dermatological Research.

[10]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. , 2005, European journal of cancer.

[11]  Sabine Siesling,et al.  Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. , 2008, European journal of cancer.

[12]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.

[13]  J. Aitken,et al.  Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002 , 2006, Cancer Causes & Control.

[14]  V. Siskind,et al.  Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[15]  D. Duffy,et al.  Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? , 2000, American journal of human genetics.

[16]  R. MacKie,et al.  Development of melanocytic nevi in the first three years of life. , 2000, Journal of the National Cancer Institute.

[17]  E. Holly,et al.  Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. , 1995, American journal of epidemiology.

[18]  M. Janssen-Heijnen,et al.  Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  J. Cuzick,et al.  Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK: a case-control study. , 2004, European journal of cancer.

[20]  D. Easton,et al.  Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies , 1995 .

[21]  J. N. Newton Bishop,et al.  Genetics: what advice for patients who present with a family history of melanoma? , 2007, Seminars in oncology.